| Literature DB >> 32595321 |
Seok Hyun Nam1, Juhyun Park2, Tae Won Park1,3.
Abstract
Most patients with Tourette's disorder experience an uncomfortable sensory phenomenon called the premonitory urge immediately before experiencing tics. It has been suggested that premonitory urges are associated with comorbidities such as obsessive compulsive disorder, anxiety disorders, and attention-deficit/hyperactivity disorder, although these associations have been inconsistent. Most patients experience tics as a result of the premonitory urges, and after the tics occur, most patients report that the premonitory urges are temporarily relieved. As a consequence, several studies have assessed the premonitory urge and its potential therapeutic utility. Based on the concept that the premonitory urge induces tics, behavioral treatments such as Exposure and Response Prevention and Habit Reversal Therapy have been developed. However, it is still unclear whether habituation, the main mechanism of these therapies, is directly related to their effectiveness. Moreover, the observed effects of pharmacological treatments on premonitory urges have been inconsistent. Copyright: © Journal of the Korean Academy of Child and Adolescent Psychiatry.Entities:
Keywords: Behavior therapy; Comorbidity; Drug therapy; Premonitory urge; Tourette disorder
Year: 2019 PMID: 32595321 PMCID: PMC7289498 DOI: 10.5765/jkacap.180025
Source DB: PubMed Journal: Soa Chongsonyon Chongsin Uihak ISSN: 1225-729X
Studies about the effect of behavior therapy on premonitory urge severity
| References | Years | Participants | Method | Control/ comparison | Outcome |
|---|---|---|---|---|---|
| Hoogduin et al [ | 1997 | 3 adults & 1 child with TD | ERP, 2-hours 10 sessions | ERP only | 3 adults of the 4, PMU habituation both within & between sessions |
| Himle et al [ | 2007 | 5 children & adolescents with TD or PTD | ERP, 5 consecutive, 5-min xperimental trials | ERP only | 4 of the 5 children demonstrated reliable suppression |
| Of the 4 children who achieved suppression, 3 failed PMU suppression | |||||
| Verdellen et al [ | 2008 | 19 adults & child with TD 15 males & 4 females | ERP, 2-hours 10 sessions | ERP only | SUD score of 19 subjects, PMU habituationboth within & between sessions |
| Specht et al [ | 2013 | 12 children & adolescents with TD or PTD | ERP, 10 min baseline control 3 sessions & 40 min tic suppression 2 sessions | Baseline control | Urge ratings did not show the expected increase during the initial periods of tic suppression, nor a subsequent decline in urge ratings during prolonged, effective tic suppression |
| Houghton et al [ | 2017 | 126 youths & 122 adults with TD | CBIT, 10 wks 8 sessions | PST | Adults showed a significant trend of declining PMU severity |
| But results failed to demonstrate that HRT specifically caused changes in PMU severity. Children failed to show any significant changes in PMU severity |
CBIT: Comprehensive Behavioral Intervention for Tics, ERP: Exposure and Response Prevention, HRT: Habit Reversal Therapy, PMU: premonitory urge, PST: psychoeducation and supportive psychotherapy, PTD: persistent tic disorder, SUD: Subjective Units of Distress Scale, TD: Tourette’s disorder
Studies about the effect of pharmacological treatments on PMU severity
| References | Years | Participants | Medication (number) | Dose | Response of PMU | Complications (number or %) |
|---|---|---|---|---|---|---|
| Scott et al [ | 1996 | A 13 year old boy | Botulinum toxin I.M. in vocal cord | 30 U | Decreased markedly | Hypophonia |
| Salloway et al [ | 1996 | A 28 year old male | Botulinum toxin I.M. in vocal cord | Initial dose 1.25 U per side 3.75 U every 3 months | Not specified | Hypophonia |
| Trimble et al [ | 1998 | A 34 year old male | Botulinum toxin I.M. in vocal cord | 3.75 mouse unit per side | Not specified | Hypophonia |
| Kwak et al [ | 2000 | 30 males & 5 females 23.3±15.5(8-69)year old | Botulinum toxin I.M. in cervical(17), upper face(14), lower face(7), vocal cord(4), other(3) | 119.9±70.1 U per visit total dose 502.1±779.4 U | Decreased markedly | Mild neck weakness(4) Transient ptosis(2) Mild dysphagia(2) Hypophonia(1) etc |
| Jankovic et al [ | 2010 | 26 males & 3 females 16.5±9.89(7-65)year old | Topiramate p.o. | Initial dose 25 mg Titration depending on tolerance to 200 mg Mean dose 118 mg | YGTSS:14.29±10.47 at baseline →5.00±9.88 at visit 5 PMU CGI improved | Headache(3) Diarrhea(3) Abdominal pain(2)Drowsiness(2)etc |
| Gilbert et al [ | 2014 | 15 males & 3 females 36.2(18-63)year old | Ecopipam p.o. | 1-2 wks 50 mg daily 3-8 wks 100 mg daily | YGTSS:30.6 at baseline →25.3 at 8 wks there was no significant change in PMU | Sedation(39%) Fatigue(33%) Insomnia(33%) Somnolence(28%)etc |
CGI: Clinical Global Improvement, PMU: premonitory urge, YGTSS: Yale Global Tic Severity Scale